Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Cortical and Striatal Reward Processing in Parkinson's Disease Psychosis.

Garofalo S, Justicia A, Arrondo G, Ermakova AO, Ramachandra P, Tudor-Sfetea C, Robbins TW, Barker RA, Fletcher PC, Murray GK.

Front Neurol. 2017 Apr 24;8:156. doi: 10.3389/fneur.2017.00156. eCollection 2017.

2.

Theranostic Biomarkers for Schizophrenia.

Perkovic MN, Erjavec GN, Strac DS, Uzun S, Kozumplik O, Pivac N.

Int J Mol Sci. 2017 Mar 30;18(4). pii: E733. doi: 10.3390/ijms18040733. Review.

3.

Modulation of Synaptic Plasticity in the Cortex Needs to Understand All the Players.

Meunier CN, Chameau P, Fossier PM.

Front Synaptic Neurosci. 2017 Feb 1;9:2. doi: 10.3389/fnsyn.2017.00002. eCollection 2017. Review.

4.

Altered Insular Function during Aberrant Salience Processing in Relation to the Severity of Psychotic Symptoms.

Walter A, Suenderhauf C, Smieskova R, Lenz C, Harrisberger F, Schmidt A, Vogel T, Lang UE, Riecher-Rössler A, Eckert A, Borgwardt S.

Front Psychiatry. 2016 Nov 23;7:189. eCollection 2016.

5.

The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia.

Griebel G, Pichat P, Boulay D, Naimoli V, Potestio L, Featherstone R, Sahni S, Defex H, Desvignes C, Slowinski F, Vigé X, Bergis OE, Sher R, Kosley R, Kongsamut S, Black MD, Varty GB.

Sci Rep. 2016 Oct 13;6:35320. doi: 10.1038/srep35320.

6.

Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanisms.

Li M.

J Psychopharmacol. 2016 Aug;30(8):749-70. doi: 10.1177/0269881116654697. Epub 2016 Jul 1. Review.

7.

Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.

Ofori E, Zhu XY, Etukala JR, Peprah K, Jordan KR, Adkins AA, Bricker BA, Kang HJ, Huang XP, Roth BL, Ablordeppey SY.

Bioorg Med Chem. 2016 Aug 15;24(16):3464-71. doi: 10.1016/j.bmc.2016.05.053. Epub 2016 May 27.

PMID:
27312422
8.

The neural underpinnings of cognitive flexibility and their disruption in psychotic illness.

Waltz JA.

Neuroscience. 2017 Mar 14;345:203-217. doi: 10.1016/j.neuroscience.2016.06.005. Epub 2016 Jun 7. Review.

PMID:
27282085
9.

Selective serotonin 5-HT1A receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI study.

Becker G, Bolbos R, Costes N, Redouté J, Newman-Tancredi A, Zimmer L.

Sci Rep. 2016 May 23;6:26633. doi: 10.1038/srep26633.

10.

Multiple D2 heteroreceptor complexes: new targets for treatment of schizophrenia.

Borroto-Escuela DO, Pintsuk J, Schäfer T, Friedland K, Ferraro L, Tanganelli S, Liu F, Fuxe K.

Ther Adv Psychopharmacol. 2016 Apr;6(2):77-94. doi: 10.1177/2045125316637570. Epub 2016 Mar 10. Review.

11.

Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges.

Lee JK, Nam DH, Lee J.

Oncol Lett. 2016 Feb;11(2):1281-1286. Epub 2016 Jan 7.

12.

Dysfunctional insular connectivity during reward prediction in patients with first-episode psychosis.

Schmidt A, Palaniyappan L, Smieskova R, Simon A, Riecher-Rössler A, Lang UE, Fusar-Poli P, McGuire P, Borgwardt SJ.

J Psychiatry Neurosci. 2016 Oct;41(6):367-376.

13.

Serotonin 2a Receptor and Serotonin 1a Receptor Interact Within the Medial Prefrontal Cortex During Recognition Memory in Mice.

Morici JF, Ciccia L, Malleret G, Gingrich JA, Bekinschtein P, Weisstaub NV.

Front Pharmacol. 2015 Dec 23;6:298. doi: 10.3389/fphar.2015.00298. eCollection 2015.

14.

Comorbid Obsessive-Compulsive Symptoms in Schizophrenia: Insight into Pathomechanisms Facilitates Treatment.

Zink M.

Adv Med. 2014;2014:317980. doi: 10.1155/2014/317980. Epub 2014 Jun 11. Review.

15.

Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective.

Tse L, Barr AM, Scarapicchia V, Vila-Rodriguez F.

Curr Neuropharmacol. 2015;13(3):395-406. Review.

16.
17.

Altered G Protein Coupling in Olfactory Neuroepithelial Cells From Patients With Schizophrenia.

Borgmann-Winter KE, Wang HY, Ray R, Willis BR, Moberg PJ, Rawson NE, Gur RE, Turetsky BI, Hahn CG.

Schizophr Bull. 2016 Mar;42(2):377-85. doi: 10.1093/schbul/sbv129. Epub 2015 Sep 15.

18.

Antipsychotic drugs on maternal behavior in rats.

Li M.

Behav Pharmacol. 2015 Sep;26(6):616-26. doi: 10.1097/FBP.0000000000000168. Review.

19.

Catha edulis chewing effects on treatment of paranoid schizophrenic patients.

Kotb El-Sayed MI, Amin HK.

Neuropsychiatr Dis Treat. 2015 Apr 15;11:1067-76. doi: 10.2147/NDT.S81011. eCollection 2015.

20.

Profile of aripiprazole in the treatment of bipolar disorder in children and adolescents.

Kirino E.

Adolesc Health Med Ther. 2014 Nov 27;5:211-21. doi: 10.2147/AHMT.S50015. eCollection 2014. Review.

Supplemental Content

Support Center